Xilio Therapeutics has dosed the first patient in its Phase 1/2 clinical trial of XTX501, a novel bispecific antibody targeting PD-1 and masked IL-2, in metastatic non-small cell lung cancer (NSCLC) patients previously treated with anti-PD(L)-1 therapy. XTX501 aims to improve immune response by combining tumor-selective IL-2 activation with PD-1 inhibition, potentially offering a new backbone immunotherapy with fewer side effects. Initial Phase 1 data is expected in Q4 2027, and Xilio will present trial details at the upcoming Society for Immunotherapy of Cancer meeting.
Xilio Therapeutics' clinical trial news provides context for readers following health innovation. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 26, 2026 18:11 WIB: out of 150 priced stocks, 82 rose and 35 fell. Johnson & Johnson traded at USD 266.99 with a 1-day change of +1.21%, Immunovant Inc. was at USD 28.03 with a -1.34% change, and Tango Therapeutics Inc. stood at USD 23.61 with a +1.16% change.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
